Benitec Historical Balance Sheet

BNTC Stock

USD 10.09 0.36 3.70%

Trend analysis of Benitec Biopharma Ltd balance sheet accounts such as Other Current Liab of 3.5 M, Total Current Liabilities of 5.2 M or Total Stockholder Equity of 49.6 M provides information on Benitec Biopharma's total assets, liabilities, and equity, which is the actual value of Benitec Biopharma to its prevalent stockholders. By breaking down trends over time using Benitec Biopharma balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Covid

Financial Statement Analysis is much more than just reviewing and examining Benitec Biopharma latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Benitec Biopharma is a good buy for the upcoming year.

Benitec Biopharma Inventory

59,850

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Benitec Biopharma Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

About Benitec Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Benitec Biopharma at a specified time, usually calculated after every quarter, six months, or one year. Benitec Biopharma Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Benitec Biopharma and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Benitec currently owns. An asset can also be divided into two categories, current and non-current.

Benitec Biopharma Balance Sheet Chart

At present, Benitec Biopharma's Other Current Liabilities is projected to increase significantly based on the last few years of reporting. The current year's Total Current Liabilities is expected to grow to about 5.2 M, whereas Net Debt is projected to grow to (48.1 M).

Total Assets Other Current Liab Total Current Liabilities Total Stockholder Equity Retained Earnings Total Current Assets

Add Fundamental

Total Assets

Total assets refers to the total amount of Benitec Biopharma assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Benitec Biopharma books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Benitec Biopharma balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Benitec Biopharma Ltd are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Total Stockholder Equity

The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.

Retained Earnings

The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.

Total Current Assets

The total value of all assets that are expected to be converted into cash within one year or during the normal operating cycle.

Most accounts from Benitec Biopharma's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Benitec Biopharma current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Benitec Biopharma Ltd. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.

	2021	2022	2023	2024 (projected)
Other Current Liabilities	1.9M	2.6M	3.3M	3.5M
Total Assets	6.0M	4.5M	52.2M	54.8M

Other Current Liab Total Assets

Benitec Biopharma balance sheet Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Inventory	Other Current Assets	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Common Stock	Property Plant Equipment	Net Tangible Assets	Short Term Investments	Non Current Liabilities Total	Net Invested Capital	Net Working Capital
Total Assets		0.42	0.45	0.99	-0.38	-1.0	-0.38	0.17	1.0	-0.37	1.0	-0.21	-0.07	0.71	0.17	-0.15	0.39	0.27	1.0	-0.07	-0.28	-0.01	-0.16	-0.22	0.93	0.93
Other Current Liab	0.42		0.92	0.33	0.4	-0.4	-0.95	0.16	0.44	0.46	0.44	-0.19	-0.7	0.91	-0.49	0.6	0.93	0.92	0.41	-0.7	0.49	-0.8	-0.28	-0.21	0.53	0.53
Total Current Liabilities	0.45	0.92		0.36	0.39	-0.43	-0.92	0.52	0.47	0.42	0.47	-0.13	-0.64	0.91	-0.5	0.59	1.0	0.92	0.44	-0.64	0.46	-0.8	-0.02	0.11	0.56	0.56
Total Stockholder Equity	0.99	0.33	0.36		-0.45	-0.99	-0.29	0.13	0.99	-0.43	0.99	-0.2	0.0	0.64	0.24	-0.23	0.29	0.18	1.0	0.0	-0.34	0.08	-0.16	-0.24	0.91	0.91
Property Plant And Equipment Net	-0.38	0.4	0.39	-0.45		0.39	-0.54	0.07	-0.35	0.98	-0.35	-0.18	-0.76	0.21	-0.59	0.45	0.46	0.57	-0.4	-0.76	0.89	-0.74	-0.01	0.3	-0.16	-0.16
Net Debt	-1.0	-0.4	-0.43	-0.99	0.39		0.36	-0.17	-1.0	0.37	-1.0	0.24	0.08	-0.7	-0.18	0.16	-0.37	-0.26	-1.0	0.08	0.27	0.0	0.19	0.22	-0.92	-0.92
Retained Earnings	-0.38	-0.95	-0.92	-0.29	-0.54	0.36		-0.21	-0.41	-0.6	-0.41	0.23	0.83	-0.9	0.59	-0.63	-0.93	-0.96	-0.36	0.83	-0.62	0.85	0.21	0.03	-0.52	-0.51
Accounts Payable	0.17	0.16	0.52	0.13	0.07	-0.17	-0.21		0.17	0.04	0.17	0.16	-0.01	0.29	-0.2	0.24	0.49	0.31	0.17	-0.01	0.08	-0.27	0.58	0.69	0.2	0.2
Cash	1.0	0.44	0.47	0.99	-0.35	-1.0	-0.41	0.17		-0.33	1.0	-0.25	-0.12	0.73	0.15	-0.13	0.41	0.31	1.0	-0.12	-0.24	-0.05	-0.19	-0.22	0.94	0.94
Non Current Assets Total	-0.37	0.46	0.42	-0.43	0.98	0.37	-0.6	0.04	-0.33		-0.33	-0.16	-0.8	0.24	-0.64	0.56	0.49	0.59	-0.38	-0.8	0.9	-0.75	-0.04	0.3	-0.14	-0.15
Cash And Short Term Investments	1.0	0.44	0.47	0.99	-0.35	-1.0	-0.41	0.17	1.0	-0.33		-0.24	-0.12	0.73	0.15	-0.13	0.41	0.31	1.0	-0.12	-0.24	-0.05	-0.19	-0.22	0.94	0.94
Net Receivables	-0.21	-0.19	-0.13	-0.2	-0.18	0.24	0.23	0.16	-0.25	-0.16	-0.24		0.47	-0.23	-0.42	-0.16	-0.15	-0.27	-0.2	0.47	-0.03	0.07	0.78	0.27	-0.07	-0.07
Common Stock Total Equity	-0.07	-0.7	-0.64	0.0	-0.76	0.08	0.83	-0.01	-0.12	-0.8	-0.12	0.47		-0.6	0.51	-0.59	-0.68	-0.81	-0.05	1.0	-0.78	0.81	0.34	-0.07	-0.21	-0.2
Common Stock Shares Outstanding	0.71	0.91	0.91	0.64	0.21	-0.7	-0.9	0.29	0.73	0.24	0.73	-0.23	-0.6		-0.37	0.35	0.88	0.86	0.7	-0.6	0.35	-0.68	-0.2	-0.15	0.8	0.8
Inventory	0.17	-0.49	-0.5	0.24	-0.59	-0.18	0.59	-0.2	0.15	-0.64	0.15	-0.42	0.51	-0.37		-0.45	-0.52	-0.54	0.18	0.51	-0.78	0.75	-0.35	-0.37	-0.13	-0.12
Other Current Assets	-0.15	0.6	0.59	-0.23	0.45	0.16	-0.63	0.24	-0.13	0.56	-0.13	-0.16	-0.59	0.35	-0.45		0.62	0.64	-0.16	-0.59	0.41	-0.53	-0.08	0.22	-0.11	-0.12
Total Liab	0.39	0.93	1.0	0.29	0.46	-0.37	-0.93	0.49	0.41	0.49	0.41	-0.15	-0.68	0.88	-0.52	0.62		0.94	0.37	-0.68	0.52	-0.83	-0.04	0.11	0.5	0.49
Property Plant And Equipment Gross	0.27	0.92	0.92	0.18	0.57	-0.26	-0.96	0.31	0.31	0.59	0.31	-0.27	-0.81	0.86	-0.54	0.64	0.94		0.26	-0.81	0.62	-0.89	-0.18	-0.01	0.42	0.41
Total Current Assets	1.0	0.41	0.44	1.0	-0.4	-1.0	-0.36	0.17	1.0	-0.38	1.0	-0.2	-0.05	0.7	0.18	-0.16	0.37	0.26		-0.05	-0.29	0.01	-0.16	-0.22	0.93	0.93
Common Stock	-0.07	-0.7	-0.64	0.0	-0.76	0.08	0.83	-0.01	-0.12	-0.8	-0.12	0.47	1.0	-0.6	0.51	-0.59	-0.68	-0.81	-0.05		-0.78	0.81	0.34	-0.07	-0.21	-0.2
Property Plant Equipment	-0.28	0.49	0.46	-0.34	0.89	0.27	-0.62	0.08	-0.24	0.9	-0.24	-0.03	-0.78	0.35	-0.78	0.41	0.52	0.62	-0.29	-0.78		-0.87	0.04	0.26	-0.01	-0.02
Net Tangible Assets	-0.01	-0.8	-0.8	0.08	-0.74	0.0	0.85	-0.27	-0.05	-0.75	-0.05	0.07	0.81	-0.68	0.75	-0.53	-0.83	-0.89	0.01	0.81	-0.87		0.02	-0.13	-0.24	-0.24
Short Term Investments	-0.16	-0.28	-0.02	-0.16	-0.01	0.19	0.21	0.58	-0.19	-0.04	-0.19	0.78	0.34	-0.2	-0.35	-0.08	-0.04	-0.18	-0.16	0.34	0.04	0.02		0.71	-0.07	-0.07
Non Current Liabilities Total	-0.22	-0.21	0.11	-0.24	0.3	0.22	0.03	0.69	-0.22	0.3	-0.22	0.27	-0.07	-0.15	-0.37	0.22	0.11	-0.01	-0.22	-0.07	0.26	-0.13	0.71		-0.13	-0.14
Net Invested Capital	0.93	0.53	0.56	0.91	-0.16	-0.92	-0.52	0.2	0.94	-0.14	0.94	-0.07	-0.21	0.8	-0.13	-0.11	0.5	0.42	0.93	-0.21	-0.01	-0.24	-0.07	-0.13		1.0
Net Working Capital	0.93	0.53	0.56	0.91	-0.16	-0.92	-0.51	0.2	0.94	-0.15	0.94	-0.07	-0.2	0.8	-0.12	-0.12	0.49	0.41	0.93	-0.2	-0.02	-0.24	-0.07	-0.14	1.0

Click cells to compare fundamentals

Benitec Biopharma Account Relationship Matchups

Benitec Biopharma balance sheet Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	11.6M	21.4M	6.0M	4.5M	52.2M	54.8M
Other Current Liab	662K	882K	1.9M	2.6M	3.3M	3.5M
Total Current Liabilities	1.1M	1.4M	2.5M	4.0M	4.9M	5.2M
Total Stockholder Equity	10.2M	20.0M	2.9M	202K	47.2M	49.6M
Property Plant And Equipment Net	769K	577K	993K	613K	449K	517.7K
Net Debt	(9.4M)	(19.6M)	(3.3M)	(1.9M)	(50.6M)	(48.1M)
Retained Earnings	(116.6M)	(130.1M)	(148.3M)	(167.9M)	(190.3M)	(199.8M)
Accounts Payable	282K	274K	422K	1.1M	1.4M	801.4K
Cash	9.8M	19.8M	4.1M	2.5M	50.9M	53.4M
Non Current Assets Total	778K	771K	1.2M	735K	536K	583.5K
Cash And Short Term Investments	9.8M	19.8M	4.1M	2.5M	50.9M	53.4M
Net Receivables	59K	25K	3K	55K	229K	217.6K
Common Stock Shares Outstanding	60.1K	252.7K	480.7K	1.4M	4.1M	4.3M
Liabilities And Stockholders Equity	11.6M	21.4M	6.0M	4.5M	52.2M	54.8M
Inventory	1.0	948K	1.8	13K	63K	59.9K
Other Current Assets	1K	814K	755K	1.3M	579K	480.1K
Other Stockholder Equity	128.8M	151.6M	152.5M	168.9M	238.4M	250.3M
Total Liab	1.3M	1.4M	3.1M	4.3M	5.0M	5.2M
Property Plant And Equipment Gross	769K	577K	993K	1.9M	1.9M	1.9M
Total Current Assets	10.8M	20.6M	4.8M	3.7M	51.7M	54.3M
Accumulated Other Comprehensive Income	(2.0M)	(1.5M)	(1.2M)	(830K)	(892K)	(847.4K)
Property Plant Equipment	769K	577K	993K	613K	705.0K	511.4K
Net Tangible Assets	10.2M	20.0M	2.9M	202K	181.8K	172.7K
Non Currrent Assets Other	(148K)	194K	160K	122K	87K	61.7K
Other Assets	9K	194K	160K	122K	140.3K	147.3K
Non Current Liabilities Total	213K	1.1M	559K	284K	38K	36.1K
Capital Lease Obligations	405K	213K	811K	559K	284K	249.9K
Short Term Debt	192K	213K	252K	275K	284K	298.2K
Short Long Term Debt Total	405K	213K	811K	559K	284K	277.7K
Net Invested Capital	10.2M	20.0M	2.9M	202K	47.2M	49.6M
Net Working Capital	9.7M	19.2M	2.3M	(249K)	46.8M	49.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

V	Visa Class A
GOOG	Alphabet Inc Class C
GOOG	Alphabet Inc Class C

When determining whether Benitec Biopharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Benitec Biopharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Benitec Biopharma Ltd Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Benitec Biopharma Ltd Stock:

How To Invest In Benitec

Details

Is Benitec Stock a good investment?

Details

What is Benitec Biopharma's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

You can also try the Efficient Frontier module to plot and analyze your portfolio and positions against risk-return landscape of the market..

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Benitec Biopharma. If investors know Benitec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Benitec Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(5.51)

Revenue Per Share

0.003

Quarterly Revenue Growth

0.125

Return On Assets

(0.50)

Return On Equity

(0.92)

The market value of Benitec Biopharma is measured differently than its book value, which is the value of Benitec that is recorded on the company's balance sheet. Investors also form their own opinion of Benitec Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Benitec Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Benitec Biopharma's market value can be influenced by many factors that don't directly affect Benitec Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Benitec Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if Benitec Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Benitec Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Benitec Historical Balance Sheet

Benitec Biopharma Inventory

59,850

About Benitec Balance Sheet Analysis

Benitec Biopharma Balance Sheet Chart

Total Assets

Total Current Liabilities

Total Stockholder Equity

Retained Earnings

Total Current Assets

Benitec Biopharma balance sheet Correlations

Benitec Biopharma Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Benitec Biopharma balance sheet Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash	+ 1.0	Total Assets
Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Total Liab	+ 1.0	Total Current Liabilities
Total Current Assets	+ 1.0	Total Stockholder Equity
Cash And Short Term Investments	+ 1.0	Cash

Total Current Assets	- 1.0	Net Debt
Cash And Short Term Investments	- 1.0	Net Debt
Cash	- 1.0	Net Debt
Net Debt	- 1.0	Total Assets
Net Debt	- 0.99	Total Stockholder Equity
Property Plant And Equipment Gross	- 0.96	Retained Earnings